Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Disaggregation of Revenue (Details)

v3.22.1
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue $ 117,169 $ 115,533
Clinical Services    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue 98,791 96,487
Clinical Services | Client direct billing    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue 65,014 60,709
Clinical Services | Commercial Insurance    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue 18,288 18,574
Clinical Services | Medicare and Medicaid    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue 15,465 17,150
Clinical Services | Self-Pay    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue 24 54
Pharma Services    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Total net revenue $ 18,378 $ 19,046